Alembic Pharmaceuticals Limited (APLLTD) — Announcement | 11 June 2026

StockFin.ai

Try Free

📢 Key Event
CARE Ratings reaffirms Alembic's commercial paper rating at A1+

💡 Investor Takeaway
The reaffirmation signals stable short-term credit health, supporting investor confidence in liquidity.

Alembic Pharmaceuticals announced that CARE Ratings reaffirmed its A1+ rating for commercial paper facilities, maintaining a rating of A1+ without any change in the assigned rating or amount of 1,100 crores. The reaffirmation underscores continued confidence in the company's short-term liquidity position and creditworthiness among investors.

📄 View Original Announcement (PDF)

📊 Stock Analysis — APLLTD ✨ Ask AI About This

About Alembic Pharmaceuticals Limited (APLLTD)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,412.51 Cr P/E: 22.9 ROE: 11.8% ROCE: 11.2%

View full APLLTD stock details →

📡 Get AI alerts when APLLTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APLLTD — Free

💡 Ask AI about this filing

"How does this affect APLLTD margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More APLLTD filings

See all APLLTD filings →

🔥 Also filed on 11 June 2026

SUNPHARMA Sun Pharmaceutical Industries Limited Corporate Action INDOTECH Indo Tech Transformers Limited Financial Results PATELRMART Patel Retail Limited Financial Results AGSTRA AGS Transact Technologies Limited Financial Results ASTRAL Astral Limited Announcement AVANTIFEED Avanti Feeds Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when APLLTD files new disclosures

Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APLLTD — Free

Free account · 2 AI queries/day